Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Enzo Biochem (ENZ) Insider Trading & Ownership

Enzo Biochem logo

Enzo Biochem (NYSE:ENZ) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.40%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$226.37K
Number Of
Insiders Selling
(Last 3 Years)
0
Get ENZ Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enzo Biochem stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ENZ Insider Buying and Selling by Quarter

Enzo Biochem Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/13/2023James G WolfMajor ShareholderBuy5,000$1.28$6,400.00  
2/10/2023James G WolfMajor ShareholderBuy5,000$1.29$6,450.00  
1/27/2023James G WolfMajor ShareholderBuy11,800$1.40$16,520.00  
11/23/2022Hamid ErfanianCEOBuy100,000$1.97$197,000.00  
(Data available from 1/1/2013 forward)

ENZ Insider Trading Activity - Frequently Asked Questions

The list of insiders at Enzo Biochem includes Hamid Erfanian, and James G Wolf. Learn more on insiders at ENZ.

11.40% of Enzo Biochem stock is owned by insiders. Learn more on ENZ's insider holdings.

Enzo Biochem Key Executives

  • Ms. Kara Cannon (Age 55)
    CEO & Director
    Compensation: $990.78k
  • Ms. Patricia Eckert CPA (Age 46)
    Chief Financial Officer
    Compensation: $400.06k


This page (NYSE:ENZ) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners